Treatments and supplements · Transdermal estrogen patch
Is the estrogen patch safer than pills for menopause symptoms?
What we can tell you today: how thoroughly this has been studied.
Well studied
10 studies, including 2 that bring together the results of several trials in people.
5 Repeated evidence 2 studies
4 Large controlled trial 6 studies
3 Small study in people 2 studies
This says how thoroughly something has been studied — not whether it works for you. What each study actually found is in the study itself, and in the plain-language write-ups we are adding.
Appears under: Menopause and hormones · Skin aging · Hair and nails
The studies
- 5 Repeated evidence
The Effect of Transdermal Estrogen Patch Use on Cardiovascular Outcomes: A Systematic Review.
2018 · Journal of women's health (2002)
- 5 Repeated evidence
Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis.
2017 · Climacteric : the journal of the International Menopaus
- 4 Large controlled trial
Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
2018 · Menopause (New York, N.Y.) · 727 participants · manufacturer helped fund this
- 4 Large controlled trial
Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
2012 · Menopause (New York, N.Y.) · 119 participants
- 4 Large controlled trial
Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
2005 · Obstetrics and gynecology · 417 participants
- 4 Large controlled trial
Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.
2000 · Arzneimittel-Forschung · 156 participants
- 4 Large controlled trial
Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
1998 · Maturitas · 2,459 participants
- 4 Large controlled trial
[Splenopeptides for climacteric complaints. Comparison of ovarian stimulation with transdermal estradiol substitution].
1995 · Arzneimittel-Forschung · 256 participants
- 3 Small study in people
Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study.
2020 · Journal of cosmetic dermatology · manufacturer helped fund this
- 3 Small study in people
Hypertrichotic patches as a mosaic manifestation of Proteus syndrome.
2021 · Journal of the American Academy of Dermatology